Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 787
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can hair loss be reversed with Oxy133, a sterol based drug candidate?

Hair loss can affect both men and women, often leaving a negative impact on the affected person’s life...

Can we use our immune cells to fight lung disease?

Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

What's Calcium's role in heart and kidney disease?

Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes...

Backer Badge Funded